Pharma Valuations and Investor Caution

Jack outlines recent analyst views on pharma's cheap valuations and the key risks weighing on drug stocks.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!